The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies

Background: Although infliximab has been recommended for the second-line treatment of seronegative spondyloarthropathy- or juvenile idiopathic arthritis-related uveitis, the issue of its systemic efficacy and safety in a broader diversity of refractory noninfectious uveitis is debatable. To assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Anji, Liu, Deng, Chen, Huini, Yang, Guancui, Xiong, Chen, Shuai, Yu, He, Linqian, Guo, Zepeng, Zhang, Liangwen, Yang, Yuan, Cui, Beibei, Shuai, Shiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481770/
https://www.ncbi.nlm.nih.gov/pubmed/34603013
http://dx.doi.org/10.3389/fphar.2021.620340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481770/
https://www.ncbi.nlm.nih.gov/pubmed/34603013
http://dx.doi.org/10.3389/fphar.2021.620340

Ejemplares similares